Related Experiment Video

Updated: Apr 25, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K

Beyond the Average Effect: Identifying the Trauma Patients Who Benefit Most from Tranexamic Acid

Eva Soler-Espejo1, Vanessa Roldán1

  • 1Department of Hematology, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), University of Murcia, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

Thrombosis and Haemostasis
|April 23, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

4.6K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 25, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

4.6K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

481
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
481
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

412
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
412

Articles linked to this work by shared authors, journal, and citation graph.

Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: A post hoc analysis of the CABANA trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts.

Journal of global health·2026

Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026

The role of comorbidity and frailty in shaping the burden of atrial fibrillation: a multinational cross-sectional survey.

Scientific reports·2026

Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort.

Journal of the American Heart Association·2026

Guiding Surgical Haemostasis in Inherited Factor VII Deficiency: Looking beyond Coagulation Factor Levels.

Thrombosis and haemostasis·2026

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Thrombosis and haemostasis·2026

Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS project.

Thrombosis and haemostasis·2026

Room-Temperature Stability of Argatroban, Danaparoid, and Fondaparinux in Plasma: A Multicenter Study.

Thrombosis and haemostasis·2026

Quantitative Proteomic Profiling of Plasma Alterations Associated with Thrombotic Risk and Insulin Resistance in Type 1 Diabetes.

Thrombosis and haemostasis·2026

Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive Summary.

Thrombosis and haemostasis·2026

Beyond the Bite: Tick Salivary Proteins Targeting Hemostasis and Inflammation; Implications for Cardiovascular Disease.

Thrombosis and haemostasis·2026

Correction: Synergistic adsorption of ciprofloxacin on an amine-functionalized Zn-MOF/chitosan-polyethylenimine composite sponge: experimental and statistical optimization and biological activity.

RSC advances·2026

Effective removal of toxic methylene blue dye using ZnO/nanolignin composite: kinetic, isotherm and thermodynamic study.

BMC chemistry·2026

ZDHHC8-mediated S-palmitoylation of RAD21 causes mitochondrial dysfunction in diabetic nephropathy via inhibiting ACSM3 transcription.

Cell death and differentiation·2026

Dual-pathway mask ranking guided selective fine-tuning for backdoor purification.

Neural networks : the official journal of the International Neural Network Society·2026

Rosuvastatin-Metformin Co-Processing: Enhanced Dissolution, Oral Bioavailability, and Therapeutic Efficacy through a Solvent-Minimized Approach.

Drug development and industrial pharmacy·2026

First-in-human study on the pharmacokinetics, safety, and tolerability of single escalating doses and multiple doses of XT1061, a novel core protein allosteric modulator, in healthy Chinese subjects.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us